Table 3.
Comparison of Sokal, Hasford and EUTOS scores for cumulative incidence of complete cytogenetic response at 12 and 18 months and major molecular response at 18 months
| No. (%) | 12m-CCyR (%) | 18m-CCyR (%) | 18m-MMR (%) | |
|---|---|---|---|---|
| EUTOS | P = 0.828 | P = 0.797 | P = 0.243 | |
| Low | 129 (89.0) | 80.4 | 86.9 | 50.4 |
| High | 16 (11.0) | 81.3 | 87.5 | 75.0 |
| Sokal | P = 0.012 | P = 0.002 | P = 0.493 | |
| Low | 66 (45.5) | 87.9 | 93.1 | 57.6 |
| Intermediate | 52 (35.9) | 78.8 | 85.2 | 50.0 |
| High | 27 (18.6) | 63.0 | 69.2 | 48.1 |
| Hasford | P < 0.001 | P = 0.015 | P = 0.375 | |
| Low | 60 (41.4) | 88.3 | 92.2 | 56.8 |
| Intermediate | 72 (49.7) | 77.8 | 87.2 | 52.8 |
| High | 13 (8.9) | 53.8 | 75.0 | 38.5 |
| All patients | 145 | 80.3 | 86.9 | 52.9 |
12m-CCyR, complete cytogenetic response at 12 months; 18m-MMR, major molecular response at 18 months; EUTOS, European Treatment and Outcome Study.